Authors explored the anxiolytic effect and tolerability of monotherapy with phenazepam ( 30 patients ) and complex treatment with selank and phenazepam ( 40 patients ) in anxiety-phobic , hypochondriac and somatoform disorders ( ICD-10 items F40.2-9 , F41.1-9 , F45.0-2 ) .